New flash glucose monitor aims to make diabetes management easier and safer
NCT ID NCT07386340
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new glucose monitoring system called Eversense Gemini, which includes a flash glucose measurement feature. The goal is to see how accurate and safe it is for adults with type 1 or type 2 diabetes. About 80 participants will wear the device and have their glucose readings compared to standard measurements. The study will also track any serious side effects related to the device or its insertion and removal.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETE MELLITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Headlands Research - AMCR Institute
RECRUITINGEscondido, California, 92025, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a treadmill routine sharpen the diabetic brain?
- Can a weekly shot reverse type 2 diabetes?
- FitBit coaching may help amputees walk more after surgery
- Could a stress hormone be behind the hidden danger of low blood sugar?
- Can a heart drug tame blood sugar and weight in diabetes?
- Can a puff of insulin replace a needle for diabetes?